Latest News

The SCTO Regulatory Affairs Platform has launched the eleventh issue of Regulatory Affairs Watch, exploring the opportunities and challenges of artificial intelligence (AI) in clinical research and the evolving regulatory landscape.

The Swiss Cancer Institute shares practical insights and lessons learned from developing and conducting oncology registries and observational studies in Switzerland. Covering key aspects from study design and governance to operational oversight, the session aims to encourage discussion and the exchange of best practices for successful non-interventional oncology research.

How much time do professionals spend on clinical studies, and what process-related challenges do they face? This survey aims to assess time use and identify process-related bottlenecks experienced by professionals involved in clinical studies. It is part of a National Priority Project, which focuses on identifying and proposing high-impact use cases for AI in clinical research.

Three countries, one shared commitment: advancing academic clinical research. This year’s D|A|CH Symposium for Clinical Trials in Innsbruck marked an important milestone: 10 years of collaboration between clinical research organisations in Germany, Austria and Switzerland.

The SCTO has launched the 2027/28 RoR project call. The call supports collaborative projects across the SCTO CRC Network. Priority is given to projects investigating how the quality, efficiency, and transparency of clinical research practice in Switzerland can be improved by translating research findings into clinical research processes.

Working with human genetic material in Switzerland means navigating requirements set out in several different laws. This session will explain the applicable legal framework and show how consent and information requirements vary depending on the type of samples and data involved.